Seeking Alpha

Glaxosmithkline plc (GSK)

()

News & PR
Market Currents

Buzz
Twitter: GSK

Business Intelligence
Transcripts
Events
Key Developments

Analysis - Latest Articles by most recent | most commented

Pharma Spreads Holiday Cheer in Bevy of Biotech Deals

Dec 24 • The Burrill Report • 2 Comments
Sanofi Pulls the Plug on Two Drugs: Biotech's Latest Mishaps

Dec 24 • The Burrill Report • Comment!
26 Hot Stocks for 2010 and Why I Won't Buy Them

Dec 22 • Dividends4Life • 6 Comments
Sanofi-Aventis Going OTC with Chattem Buy

Dec 21 • EP Vantage • 2 Comments
Making and Breaking Biotech Deals

Dec 14 • The Burrill Report • Comment!
Biotech's Latest Failed Trials, Missed Targets

Dec 14 • The Burrill Report • 1 Comment
Glaxo-Intercell Deal Could Bring New Developments to Vaccine Market

Dec 11 • EP Vantage • Comment!
Global Pharmaceutical Industry Boosted by Rising Drug Approvals and Sales in Q3

Dec 7 • Research Recap • Comment!
H1N1: What It Means for Pharma

Dec 2 • R. Scott Raynovich • 2 Comments
Immunogen's Busy Month, Part I

Dec 1 • Ohad Hammer • Comment!
China Biotech Week in Review: Two More R&D Centers, One PE Fund, One IPO

Nov 30 • ChinaBio Today • 2 Comments
8 HealthCare Stocks with 3%+ Dividends

Nov 29 • Hao Jin • 9 Comments
Theravance, Inc.: Wait to Buy on Dip

Nov 26 • Penn Bioinvestor • 4 Comments
China Biotech Week in Review: CROs Consolidating

Nov 22 • ChinaBio Today • Comment!
GlaxoSmithKline Takes 'Three-Pronged' Approach in China to Fight H1N1 Flu

Nov 22 • ChinaBio Today • Comment!
Analyze Earnings Yield Like Warren Buffett

Nov 17 • YCHARTS.com • 1 Comment
Progenics: Are the Prospects That Bad?

Nov 16 • David Greene • Comment!
Direction of Cholesterol Debate Could Benefit Abbott Labs

Nov 16 • EP Vantage • 1 Comment
Glaxo Receives Approval for Its H1N1 Vaccine

Nov 16 • Zacks.com • Comment!
Glaxo Reports Higher Revenues in Third Quarter

Nov 12 • Zacks.com • Comment!
EFA: Diversify Your Portfolio Outside the U.S.

Nov 8 • Hao Jin • 4 Comments
The Top 4 Healthcare Dividend Stocks: Covered Call Trades

Nov 6 • Double Dividend Stocks • 2 Comments
A 130 / 30 Global Pharma Strategy

Nov 5 • Mike Havrilla • 2 Comments
Enlightened-American Portfolio: Up 33.5% YTD with Cash Hoard Growing

Nov 4 • Davy Bui • 2 Comments
Equities Update: Upward Mobility

Nov 2 • Midnight Trader • 4 Comments
Trial Results Bode Well for Human Genome Sciences

Nov 2 • EP Vantage • Comment!
This Week in Biotech: More Treats than Tricks

Nov 1 • The Burrill Report • Comment!
Healthcare Profits: Assessing Company Sensitivity to Obamacare

Oct 30 • Richard Shaw • 11 Comments
Stock Screener: 10 Foreign Stocks with Caps Above $100B, Yields Above 3%

Oct 29 • David Hunkar • Comment!
GlaxoSmithKline Wins FDA Approval for Cancer Drug

Oct 28 • Zacks.com • Comment!
SuperGen-Glaxo Deal Couldn't Have Come at a Better Time

Oct 27 • EP Vantage • 2 Comments
Tough Decisions for Antigenics

Oct 22 • EP Vantage • 3 Comments
GlaxoSmithKline Receives FDA Approval for Renal Cancer Treatment

Oct 21 • Zacks.com • Comment!
BioMed News Bytes: Angiotech, BioSante, HGSI

Oct 20 • Mike Havrilla • 1 Comment
Biotech Companies Turn to Capital Markets

Oct 18 • The Burrill Report • Comment!
October FDA Calendar Stocks: Tricks or Treats?

Oct 16 • Mike Havrilla • 1 Comment
China Biotech Week in Review: Cross-Border Deals

Oct 11 • ChinaBio Today • 1 Comment
Buy and Hold Isn't Dead Yet

Oct 8 • John Dessauer • 16 Comments
H1N1: How to Buy into the Fear

Oct 7 • Jim Van Meerten • 1 Comment
GlaxoSmithKline Forms Vaccine JV for the China Market

Oct 7 • ChinaBio Today • Comment!
FDA Panel Backs Glaxo’s Votrient

Oct 6 • Zacks.com • Comment!

Glaxosmithkline plc (GSK)

Analysis - Latest Articles by most recent | most commented

The Seeking Alpha 100

Fastest Climbers

Top Commenters

Top Instabloggers

Top StockTalkers